Record

RefNoEC/1987/07
Previous numbersCert XXII, 54
LevelItem
TitleDoherty, Peter Charles: certificate of election to the Royal Society
Date1985
DescriptionCitation typed
CitationPeter Doherty is distinguished through having, with Rolf M. Zinkernagel, been the first to describe the important phenomenon of "MHC (major histocompatibility antigen) restriction" in T lymphocyte-cell interactions. In particular, they showed that T lymphocyte mediated killing of virally-infected cells requires the "killer" and "target" cells to share the same class I (major histocompatibility) antigens. Their discovery provided the first compelling insight into the function of class I antigens, namely self-recognition in T-cell interactions. It also provided the stimulus for a profusion of related studies which notably led to the description of the role of class II (major histocompatibility) antigens in mediating interactions between T helper/suppressor and antigen-presenting cells. His studies have made outstanding contributions to anti-viral immunity and the comprehension of the basis of recognition between immunocompetent cells.
AccessStatusClosed
Add to My Items

    Collection highlights

    Browse the records of some of our collections, which cover all branches of science and date from the 12th century onwards. These include the published works of Fellows of the Royal Society, personal papers of eminent scientists, letters and manuscripts sent to the Society or presented at meetings, and administrative records documenting the Society's activities since our foundation in 1660.

    The Royal Society

    The Royal Society is a Fellowship of many of
    the world's most eminent scientists and is the
    oldest scientific academy in continuous existence.
    Registered charity number 207043

    Website design ©CalmView



    CONTACT US

    + 44 207 451 2500
    (Lines open Mon-Fri, 9:00-17:00. Excludes bank holidays)

    6-9 Carlton House Terrace, London SW1Y 5AG

    Email Us →

    SUBSCRIBE

    Subscribe to our newsletters to be updated with the
    latest news on innovation, events, articles and reports.

    Subscribe →

    © CalmView